SANDRA MACSWEENEY: Open Payments
NPI 1841474715 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 50 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $499 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $744 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $199 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Novo Nordisk Inc | 6 | $120 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Lilly USA, LLC | 4 | $65 |
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Axsome Therapeutics, Inc. | 2 | $41 |
Products named: AIRSUPRA, CAPLYTA, BREZTRI, AMVUTTRA, RECORLEV, Ozempic, TZIELD, MOUNJARO.
Industry payments across FL — which companies pay providers there.
